Therefore, the diminution of adiponectin (an anti-inflammatory adipokine) and exacerbation of leptin and YKL-40 (pro-inflammatory cytokines) in normal-weight breast cancer subjects may be associated with a more aggressive tumour phenotype. This evidence concerns the gene ADIPOQ and breast carcinoma.